慢性鼻炎的个人和社会经济负担 带有或没有鼻的鼻
Kjell Erik Julius Håkansson1, Steven Arild Wuyts Andersen2, Anders Løkke3,4
1Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, 2650 Hvidovre, Denmark.
Medical sciences (Basel, Switzerland)
|February 20, 2026
概括
慢性鼻炎 (CRS) 严重影响财政,每年损失社会数百万美元. 由于这种上呼吸道疾病,患者面临更高的医疗费用和收入损失.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 慢性鼻炎 (CRS),包括带有 (CRSwNP) 和没有鼻息肉 (CRSsNP) 的形式,是严重的公共卫生问题.
- 尽管CRS的流行程度和对医疗保健利用的影响很大,但CRS在全国范围内的经济影响仍然在很大程度上未得到量化.
研究的目的:
- 确定慢性鼻炎 (CRS) 的综合国家财政负担.
- 从全国的角度评估与CRS相关的过度医疗保健支出,福利转移和收入损失.
主要方法:
- 利用国家数据库收集医疗保健,福利和CRS患者失去收入的年度支出数据.
- 对303,475名CRS患者的财务数据与匹配的健康人群进行了比较,以量化超额成本.
- 将CRS患者分类为CRSsNP和CRSwNP,以对财务影响进行比较分析.
主要成果:
- 与对照组相比,CRS患者每年增加了1315欧元的医疗费用,每年收入减少了1356欧元.
- 工作年龄的CRS患者 (18-64岁) 支付了每年816欧元的过度福利转移,主要是由于病假和残疾.
- 据估计,CRS的总社会负担为686,052,898欧元,系统性皮质类固醇相关疾病占20.332,825欧元,过剩的福利转移总额为每年174,394,048欧元.
结论:
- 慢性鼻炎给社会带来了巨大的财务负担,包括医疗保健,福利和个体患者的财务.
- 收入损失和医疗保健利用率增加是CRS经济影响的主要原因.
- 这些发现强调需要有效的管理策略,以减轻CRS的重大经济后果.
相关概念视频
Chronic Pharyngitis
13.0K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
13.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Epistaxis
627
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
627
Drugs Used in Upper Respiratory Disorders: Overview
744
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
744


